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Abstract 
Adult skeletal muscle stem cells, termed satellite cells are imperative to muscle regeneration. 
Much work has been performed on satellite cell identification and the subsequent activation of 
the myogenic response but the regulation of satellite cells including its activation is not well 
elucidated. The purpose of this review article is to synthesize what the literature reveals in 
regards to the current understanding of satellite cells including their contribution to muscle 
repair and growth following physiological stimuli. In addition, this review article will describe 
the recent findings on the roles of the classic developmental signaling pathways, Notch and 
Wnt, to the myogenic response in various muscle injury models. This purpose of this sum-
mary is to bring awareness of the impact that muscle contraction models have on the local and 
systemic environment of adult muscle stem cells which will be beneficial for comprehending 
and treatment development for muscle –associated ailments and other organ diseases.  
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Introduction 
Since the identification of satellite cells on ske-
letal muscle fibers in 1961(1), the field of satellite cell 
biology has progressed immensely to its recent cha-
racterization as an adult stem cell and its implications 
in regenerative medicine. Although portrayal of 
postnatal myogenesis predominates the satellite cell 
biology field, what is less known is/are the factor(s) 
responsible for satellite cell activation and the myo-
genic response. In addition, there is no confirmation 
on the overall importance of satellite cells to muscle 
repair and growth following physiological stimuli. In 
recent years, Notch and Wnt signaling have been de-
termined to be critical for postnatal myogenesis but 
limited muscle regeneration models have been uti-
lized to test these pathways (2-6). Employing a variety 
of muscle injury and growth techniques will result in 
a definitive understanding of satellite cell contribu-
tion to muscle repair and hypertrophy. With its sys-
temic effects, physiological stimuli are an ideal muscle 
model as relates to investigating the myogenic prop-
erties of muscle regeneration and growth including 
satellite cell activation. Although the amount of mus-
cle injury induced may not be as profound as artificial 
models, contraction-induced muscle injury and mus-
cle overloading exercises are identified to up-regulate 
myogenic proteins. This review will summarize the 
literature to address the interest on the effects of phy-
siological stimuli on Notch and Wnt signaling path-
ways during postnatal myogenesis. We will discuss 
the current knowledge on satellite cell regulation as 
well as the recent developments of the importance of 
Notch and Wnt signaling to muscle repair. We will 
also examine the usefulness of physiological stimuli to 
studying the regulation of satellite cell activation and 
muscle regeneration. Furthermore, we will enlighten 
the reader with what is currently known on the effects 
of physiological stimuli and muscle repair as relates to 
Notch and Wnt signaling. Int. J. Biol. Sci. 2010, 6 
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The role of satellite cells during muscle re-
generation 
Skeletal muscle has the remarkable capability to 
completely repair within a few weeks of an insult (7). 
Immediately following exposure to overt skeletal 
muscle injury (injurious contractions, chemical, freeze 
and crush), muscle degeneration occurs including 
ultrastructural damage to the contractile apparatus 
such as z-line streaming, A-band disruption, and al-
tered sarcomere length (8, 9). In addition, disruptions 
to the sarcolemma and increased cellular permeability 
renders the muscle fiber to be susceptible to the au-
togenetic response via activation of the non-lysosomal 
calpain system which further disrupts the contractile 
apparatus (10, 11).  
In the hours to days following the initial me-
chanical injury, the acute inflammatory response is 
initiated within the injured muscle fiber and is cha-
racterized by vasodilation of the microcirculation, 
increased permeability of proteins accumulation and 
infiltration of phagocytes (neutrophils, monocytes 
and macrophages) (12). Chemotactic signals derived 
from the muscle itself, resident muscle macrophages 
or the circulatory system direct the inflammatory cells 
to the injured site within the muscle fiber in which 
they function to destroy the necrotic tissue and pre-
pare the site for muscle regeneration (13, 14).  
The muscle regeneration process in postnatal 
skeletal muscle is mostly attributed to the small pop-
ulation of myogenic stem cells termed satellite cells. 
Located beneath the myofiber basal lamina, quiescent 
satellite cells comprise a small percentage of myo-
nuclei (~5% at two months of age) (15). Quiescent 
satellite cells are mitotically arrested at G0 state and 
are characterized with small cytoplasm, condensed 
chromatin and flatten shape (15). Satellite cells have 
often been identified to be Pax 7+, CD34+, CD45- and 
Sca1- (16). However, there are several markers identi-
fied to be associated with quiescent satellite cells such 
as CD34, α7-integrin, Pax-7, ABGC2, MCadherin, 
Syndecan 3/4, c-met, Cdh15, Foxk1 (formerly myo-
cyte nuclear factor), Pax3, Sox8, Sox15, Vcam1, 
CXCR4, β1 integrin, and SM/C-2.6 antibody, calcito-
nin receptor, Caveolin-1and sphingomyelin (15, 
17-26). It is improbable to identify a single marker 
discriminating quiescent satellite cells from prolife-
rating myogenic precursor cells since many  of the 
aforementioned markers may only identify specific 
subpopulations of satellite cells or stage of satellite 
cell activation.  
Following muscle injury, quiescent satellite cells 
are exposed to signals derived either from the dam-
aged muscle or elsewhere within the injured micro-
environment and the cells become activated. Many 
factors have been suggested to be responsible for ac-
tivation of satellite cells, such as muscle-derived 
growth factors including hepatocyte growth factor, 
fibroblast growth factor 2, 6, cytokines such as inter-
leukin-6, heat stress, and developmental signaling 
pathways, but the molecular/cell mechanisms lead-
ing to awakening of satellite cells and from the un-
perturbed state remain to be fully identified (2, 7, 27, 
28).  
Upon activation, satellite cells undergo increased 
cytoplasmic volume, decreased heterochromatin and 
they become mitotically active as they transition from 
G0 to G1 cell cycle phase. Once in the first cycle satel-
lite cells enter an intermediate progenitor stage and 
are known as myogenic precursor or progenitor cells 
(15). Within hours following activation, satellite cells 
up regulate the expression of basic helix-loop-helix 
transcriptional activators of the myogenic regulatory 
factor (MRF) family (MyoD, Myf5) and progress to the 
highly proliferative phase termed myoblasts. MRFs 
are essential for muscle regeneration. MyoD (-/-) null 
mice and mice with either double-knockout for MyoD 
and Myf5 genes or triple mutant of Myf5, Mrf4 and 
MyoD demonstrate a complete loss of skeletal muscle 
formation (29-32). In the days post activation, proli-
ferating myoblasts express the cell cycle arrest pro-
tein, p21 and late MRFS (Myogenin and MRF4), re-
sulting in withdrawal from the cell cycle and initiation 
of terminal differentiation to form multinucleated 
myotubes. Completion of the differentiation program 
results in fusion of myotubes with each other or with 
existing myofibers and is often identified with in-
creased expression of muscle specific Myosin Heavy 
Chain (MHC).  
Myogenin has been identified to be critical for 
myoblast differentiation as demonstrated in myoge-
nin-deficient embryos that have myoblasts but not 
myofibers due to defective myotube formation (33, 
34). MicroRNAs (miRs), which function in 
post-transcriptional modification have recently been 
identified to participate in skeletal muscle repair and 
may play a role in the transition of proliferation to 
differentiation state of myoblasts (35, 36). Exogenous 
application of miR1, miR-133 and miR-206 to lace-
rated rat TA result in enhanced muscle repair in-
cluding increased expression of MyoD and Pax7 (35). 
In embryos, miR-27b targets and down-regulates Pax3 
thereby promoting differentiation while miR-27b in-
hibitors result in continual Pax3 expression and pro-
liferation of satellite cells (36). These data suggest that 
microRNAs may provide a novel strategy for under-
standing the regulation of skeletal muscle repair par-
ticularly as relates to the transition of myoblast proli-Int. J. Biol. Sci. 2010, 6 
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feration to the differentiation stage.  
The importance of Pax 7 as relates to MRFs and 
postnatal myogenesis is a prevalent study topic in 
satellite cell biology. Upon activation and prolifera-
tion of satellite cells, Pax 7 has been identified to up 
regulate MyoD through the recruitment of histone 
methyltransferase complex (37, 38) and as myoblasts 
progress to the differentiation stage, Pax 7 expression 
is down regulated (39). However, there is also a small 
population of activated satellite cells that retain Pax 7 
expression and do not express MyoD or Myf5. These 
cells function to maintain the progenitor pool by re-
turning to a quiescent state instead of committing to 
myogenic differentiation (38, 39). The importance of 
Pax 7 to muscle regeneration may end by 21 days of 
age in rodents (32, 40). Lepper et al. (40) tracked the 
temporal fate of inactive Pax7 gene expression and 
reports that in adult mice with mutant Pax 7, myoge-
nesis was able to ensue (40). Therefore, Pax 7 may be 
critical for satellite cell activation up to a “juvenile 
age” in which young skeletal muscle is developed and 
the remaining satellite cells are not needed and go 
into quiescence.  
There is much evidence supporting the notion 
that satellite cells possess stem cell properties such as 
their ability to generate non-muscle lineages. Satellite 
cells migrated from single muscle fibers cultured on 
Matrigel formed myoblasts and myotubes but also 
expressed osteogenic and adipogenic protein markers 
suggesting that satellite cells have the potential to 
convert to other mesodermal derivatives including 
osteocytes and adipocytes (41). Myoblasts treated 
with bone morphogenic protein (BMPs) differentiate 
into osteocytes and suppress the expression of MRFs 
such as MyoD (42, 43). In addition, myoblasts convert 
to adipocytes when cultured with thiazolidinedione 
or fatty acids (44). C2C12s engineered for expression 
of CCAAT/enhancer-binding proteins (C/EBPs) 
(adipogenic protein) or BMPs (osteogenic protein) 
result in differentiation of each respective fate (45). 
MyoD (-/-) null mice are not more susceptible to 
transition to osteogenic or adipogenic fates when 
treated with BMP or thiazolidinedione respectively 
relative to control mice suggesting that MyoD is not 
critical for possession of a myogenic fate (41). In vivo 
models also show the conversion of muscle to 
non-myogenic lineages including the presence of 
adipose tissue and bone formation within muscle 
diseases such as Duchenne Muscular Dystrophic pa-
tients and mdx mice (30, 46-54). 
Another unique stem cell characteristic of satel-
lite cells are their ability to self renew (20, 22, 55-59). It 
has been suggested that a small population of acti-
vated satellite cells do not proliferate but assist in 
maintaining the quiescent satellite cell pool to ensure 
enough satellite cells are present for repairing of in-
jured skeletal muscle (20, 22, 55-57). Transplantation 
of genetically-labeled myofibers into mdx mice that 
were depleted of satellite cells result in replenishment 
of the satellite cell pool (58). There are multiple me-
chanisms for self-renewal. Activated satellite cells 
have been demonstrated to divide into 2 separate sa-
tellite cell populations, one faction that rapidly di-
vides and another group that divides at a slower rate 
and may have the duty of replenishing the satellite 
cell pool (59). Self-renewal may also occur through 
asymmetric division in which a daughter cell does not 
further divide and maintains stem-cell properties in-
cluding expression of Sca1, Notch1and Pax7 while the 
other daughter cell proliferates and progresses down 
the myogenic lineage by expressing the muscle diffe-
rentiation marker Desmin (2, 60-65). Notch inhibitor, 
Numb is asymmetrically expressed on the activated 
satellite cells and may regulate cell fate choices by 
promoting progression down the myogenic lineage 
(2). Self renewal may also occur through symmetrical 
division in which both daughter cells maintain 
stem-cell properties (66, 67). Cells that do not express 
MyoD but continue to express Pax 7 are suggested to 
be refrained for self-renewal (32). 
There is great advancement in postnatal myo-
genesis characterization as well as the recognition of 
the stem cell properties of satellite cells including their 
tactics to maintaining their numbers. The factors re-
sponsible for satellite cell regulation are under study 
and need to be determined. Ascertaining satellite cell 
regulation will have implications in muscle 
–associated ailments and disease as well as implica-
tions in stem-cell regenerative medicine.  
The role of Notch and Wnt in muscle rege-
neration 
Notch and Wnt signaling are well known to play 
a critical role in determining tissue specificity of stem 
cells by regulating cell fate decisions during embryo-
nic development (68-72). Since satellite cells are stem 
cells it is plausible to infer that Notch and Wnt are 
important for postnatal myogenesis. 
Activation of Notch signaling occurs when the 
transmembrane Notch receptor interacts with one of 
its cell-membrane-anchored DSL ligands (Del-
ta/Jagged, Serrate, or Lag2) and undergoes a series of 
cleavages from metalloproteases and γ-secretases re-
sulting in the intercellular domain of Notch (NICD) 
translocating to the nucleus  (Figure 1). Within the 
nucleus, the now active NICD interacts with tran-
scriptional repressors of the CSL family (CBF1/RBP-J, 
Suppressor of Hairless (Su[H]), and Lag-1) and con-Int. J. Biol. Sci. 2010, 6 
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verts them to transcriptional activators (NICD-CSL). 
With involvement of other proteins, the CSL-NICD 
complex regulates target genes such as Hey and Hes 
genes, which encode proteins known to be involved in 
myogenesis (68). 
Within hours to days following muscle injury 
there is increased expression of Notch signaling 
components (Delta-1, Notch-1 and active Notch) on 
activated satellite cells and neighboring muscle fi-
bers(2, 3). Up-regulation of Notch signaling promotes 
the transition of activated satellite cells to highly pro-
liferative myogenic precursor cells and myoblasts, as 
well as prevents myoblast differentiation to myotubes 
(3-6, 73, 74). Myoblast proliferation is decreased and 
differentiation is promoted when Notch activity is 
inhibited in myoblasts with Notch antagonist, 
Numb,γ-secretase inhibitor, or with small-interfering 
RNA (siRNA) knockdown of Presenilin-1 (2, 4, 75-78). 
In addition, mutations in Delta-like 1 or CSL result in 
excessive premature muscle differentiation and de-
fective muscle growth (79, 80).  
Multiple mechanisms for how Notch signaling 
prevents myoblast differentiation have been proposed 
( 8 1 - 8 7 ) .  H e s 1  o r  H e y 1  m a y  f o r m  a  c o m p l e x  w i t h  
MyoD to repress its expression resulting in inhibiting 
critical proteins for myotube formation such as Mef2D 
and Myogenin (6, 81-83, 88, 89). However, a recent 
study by Buas et al. (84) does not show an interaction 
with Hey1 and MyoD and instead proposes that Hey1 
prevents MyoD to bind to Myogenin or Mef2C pro-
moters thereby inhibiting their transcription and ul-
timately repressing muscle differentiation(84). 
Another mechanism for Notch preventing differen-
tiation is a potential cooperative effort between Notch 
and other signaling pathways to allow for sufficient 
myoblast proliferation prior to differentiation (85, 86). 
Forkhead Box O 1 transcription factor (FOXO1) pre-
vents muscle differentiation and is suggested to be 
critical for downstream Notch signaling since  siR-
NA-induced inhibition of  FOXO1 represses 
Notch-induced Hes1 activity in C2C12 cells (85). 
FOXO1 interacts with CSL of Notch resulting in up 
regulation of Hes1 promoter activity. In addition, 
Transforming Growth Factor ß signaling pathway 
(TGFß) induces Hes1 expression in C2C12 cells which 
may lead to inhibition of MyoD and progression of 
muscle differentiation (86, 87).  
Similar to Notch, canonical Wnt signaling is 
critical for muscle repair (90-94). The canonical Wnt 
signaling cascade entails soluble Wnt ligands to inte-
ract with Frizzled receptors and low-density lipo-
protein receptor-related protein co-receptors (LRP) 
(Figure 2). This coordination stimulates phosphoryla-
tion of Disheveled and inactivates GS3Kß’s phos-
phorylation of ß catenin. With the assistance of Axin, 
the de-phosphorylated and stable ß- catenin does not 
undergo ubiquitination and degradation and is in-
stead translocated to the nucleus where it binds to 
TCF/LEF1 transcription factors (95). TCF/LEF1 tran-
scription factors may directly activate MyF5 and 
MyoD or may up regulate MRF co-activators such as 
c-Jun N-terminal kinases (96-98). 
 
 
Figure 1. Notch signaling pathway. Int. J. Biol. Sci. 2010, 6 
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Figure 2. Canonical Wnt signaling pathway. 
 
There is a preponderance of evidence demon-
strating that skeletal muscle injury up regulates Wnt 
signaling (90-94). mRNA expression of Wnts5a, 5b, 7a, 
and 7b increases in muscle at four days post cardi-
otoxin-induced injury (90). At four days post myofi-
ber explantation, there is elevated expression of 
Wnt3a, Frizzled1 and 2, and Axin2 (93). Using 
TCF-optimal promoter B-galactosidase mice 
(TOPGAL mice) there is increased TCF reporter ac-
tivity in myogenic cells at two and five days post 
freeze-induced muscle injury (93). Furthermore, dif-
ferentiating myoblasts express Wnt signaling 
co-activator BCL9 (94).  
While Wnt is critical for muscle development as 
evident in no dermomyotome formation or Myf5 ex-
pression in embryonic Wnt1 and Wnt3a knockout 
mice, Wnt also contributes postnatal muscle regene-
ration (90, 93, 98). Activating Wnt signaling by treat-
ing myoblasts with lithium chloride (LiCl, which in-
hibits GSK3ß activity) results in increased MHC and 
Myogenin expression; and treating myoblasts with 
Wnt3a results in a ~ 30% increase in Desmin expres-
sion (90, 93, 99, 100). Brack et al. (94) reports a ~ 40% 
increase in muscle regeneration in myogenic cells 
with forced Wnt expression, further demonstrating 
that Wnt signaling promotes postnatal muscle repair 
(94).  
Wnt’s main role during muscle regeneration is 
myoblast differentiation and myotube fusion (99-103). 
Premature myogenic differentiation occurs in 
freeze-injured muscle injected with Wnt3a (93). Fur-
thermore, treatment of proliferation C2C12 myoblasts 
or single fiber cultures with Wnt ant agonists or se-
creted frizzled receptor proteins  (sFRPs)  repress 
myotube formation, decreases Myogenin and Mrf4 
RNA expression by ~ 50% as well as inhibits Desmin 
expression (93, 102). Moreover, there is impaired 
myotube formation and decreased Myogenin and 
MHC expressions in siRNA-induced inhibition or 
knock-out mice of Wnt co-activator BCL9 (94). Lastly, 
there is increased myogenic differentiation in choles-
terol depleted- myoblasts identified to promote nuc-
lear translocation of ß-catenin and TCF/LEF activa-
tion (103). 
Myogenesis consists of a series of orchestrated 
events that require communication of a variety of 
signaling pathways when transitioning from the 
phases of satellite cell activation to myoblast prolife-
ration and differentiation and finally, myotube for-
mation. Notch and Wnt interact during muscle de-
velopment as well as during postnatal myogenesis 
and it is plausible that this crosstalk contributes to the 
stage transitions during adult muscle repair (93, 104). 
It is suggested that Notch activity presides during 
myoblast proliferation after which there is a temporal 
switch to Wnt signaling and subsequent myoblast 
differentiation and fusion into myotubes (93). Inhi-
biting Notch (with soluble Jagged ligand or with a γ – 
secretase inhibitor) or activating Wnt (by inhibiting 
GSK3ß or adding Wnt3a) decreases Myf5 expression Int. J. Biol. Sci. 2010, 6 
 
http://www.biolsci.org 
273
and promotes muscle differentiation providing evi-
dence that Notch signaling needs to be turned off and 
Wnt turned on for differentiation to ensue (93, 100, 
103). When Notch inhibitors are administered during 
the differentiation phase there is no acceleration of 
muscle regeneration, further supporting the notion 
that Notch signaling does not participate in the later 
stages of muscle repair (93). In addition, during the 
early stages of muscle repair (24 hours) following 
cardiotoxin-induced muscle injury, Wnt inhibitor, 
sFRP2 is expressed in proliferating myoblasts and 
there is no Wnt activity (105); furthermore, adminis-
tration of Wnt inhibitor, sFRP3 to single-fiber cultures 
at early stages of muscle repair (day 2 of culture) has 
no effect on Wnt inhibition but when sFRP3 is added 
at later time points (day 3.5 of culture), Wnt expres-
sion is inhibited and there is less myoblast differen-
tiation. These data suggest that Wnt activity does not 
occur during the early proliferative stages of muscle 
repair (93). Brack et al. (93) recommends that low Wnt 
signaling is needed for a sufficient quantity of proli-
ferating myoblasts prior to myotube formation (93). 
Notch and Wnt orchestrate together for cell fate 
decisions in other systems but their roles have not 
been determined to be similar in the skeletal muscle 
model (106-108). A co-activation of Notch and Wnt 
promote proliferation of progenitor intestinal epi-
thelial cells (107). When Notch and Wnt are both ac-
tive in proliferating progenitor cells within the crypt 
region of the small intestine, the cells continue to pro-
liferate and form the intestinal absorptive cells called 
enterocytes (107). In addition, administration of 
Wnt3a to hematopoietic progenitors cultured in 
presence of Notch ligand, Delta results in increased 
Hes1 and CD7+ cells (T cells) suggesting that hema-
topoietic progenitors cells transform into T cells in the 
presence of Wnt and Notch (108).  
Determining if Wnt and Notch regulate each 
other will aid in delineating the mechanism of or-
chestration between Notch and Wnt during cell fate 
determination including postnatal myogenesis. Since 
Notch appears to dominate during myoblast prolife-
ration and Wnt signaling leads during the differentia-
tion/fusion stages of muscle repair, it is plausible to 
suggest that Notch signaling is upstream of Wnt. 
Transfection studies show that the intracellular do-
main of Notch has binding sites on LEF1 promoter 
that are different than ß-catenin sites and result in 
LEF1 transcriptional activation (109). Conversely, it 
should be noted that there is evidence suggesting Wnt 
signaling is upstream of Notch (110, 111). The Wnt 
target genes Brachyury (T-box) and LEF1/TCF1 have 
binding sites on Notch1 and Delta-like-1 (Dll1) pro-
moter and mice embryos with mutant Tbx6 function 
(downstream T box target gene) or lacking Brachyury 
do not express Dll1 (110, 111). Furthermore, in the 
presence of exogenous Wnt3a and Delta1 there is in-
creased Hes1 and Deltex1 expression in hematopoietic 
stem cells (108, 112).  
Identifying the location for the point of transition 
between Notch and Wnt signaling would be beneficial 
in determining the mechanism of Notch and Wnt or-
chestration for cell fate decisions including postnatal 
myogenesis. GSK3ß directly binds to Notch 1 intra-
cellular domain (Notch1IC) and facilitates Notch sig-
naling so it seems plausible that GSK3ß may be a 
critical juncture between Notch and Wnt pathways 
during postnatal myogenesis (93, 113, 114). While 
increased Notch signaling corresponds with elevated 
GSk3ß activity (GSk3ß phosphorylated at tyrosine 216 
GSk3ßpY216) at one day post muscle injury, Wnt con-
tradicts GSk3ß activity and is low at that time point 
(93). However, as the time course of muscle repair 
progresses from one day to four days, Wnt signaling 
increases and both GSK3ß and Notch activity declines 
(93). Inhibiting GSK3ß activity in mononucleated cells 
of TOPGAL mice results in increased ß-catenin ex-
pression and Wnt reporter activity (93). In addition, 
treating myoblasts with Notch inhibitor γ-secretase, 
results in decreased GSK3ß activity (93). These data 
further confirm the corresponding relationship be-
tween GSK3ß and Notch and inverse relationship 
between GSK3ß and Wnt as well as suggests that 
GSK3ß activity may be pivotal for the transition be-
tween Notch and Wnt signaling. 
Presenilins, which assist in cleaving full-length 
Notch to its activated state, have also been suggested 
to be major players in the coordination of the Notch 
and Wnt pathways (115, 116). Presenilins have been 
identified to bind to ß-catenin and possibly participate 
in ß -catenin ubiquitination(115). In addition, there is 
increased  TCF/LEF1 transcription in Presenilin1 
knockout embryonic fibroblasts (116). These date 
suggest that Presenilins may function as mediator 
between Notch and Wnt by de-regulating Wnt sig-
naling. Besides GSK3ß and Presenilins, there is evi-
dence that Notch antagonist, Numb may be a pivotal 
point of transition between Notch and Wnt since 
forced expression of Numb on erythroid progenitor 
cells treated with exogenous Wnt5a, results in in-
creased TCF/LEF transcriptional activity (106). 
The orchestration of Notch and Wnt is crucial for 
cell fate decisions of a variety of tissues. However, 
there are conflicting reports on the mechanisms of 
their co-regulation during regenerative processes in 
skeletal muscle and other tissue models. Of particular 
interest, is understanding Notch and Wnt’s role in 
satellite cell biology such as regulating myogenic Int. J. Biol. Sci. 2010, 6 
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proteins during postnatal myogenesis. What is even 
less known is the effect of different muscle injury 
models (including physiological stimuli) in regulating 
Notch, Wnt and myogenic protein expression during 
adult muscle repair.  
 Physiological stimuli and muscle regenera-
tion and growth  
The current muscle injury models for examining 
the roles of Notch and Wnt in satellite cell regulation 
during postnatal myogenesis consist primarily of ar-
tificial techniques which do not consider the influ-
ences of other biological systems and are not easily 
applied to muscle function scenarios.  Physiological 
stimuli such as contraction-induced muscle injury 
(injurious exercise) and growth models (overload 
hypertrophy, resistance exercises) are functionally 
relevant and involve the contribution of multiple ac-
tive biological systems which are important to con-
sider when investigating sources responsible for 
muscle regenerative processes.  
A common injurious exercise model, downhill 
running (DHR), uses eccentric muscle contractions in 
which the contracting muscle is forced to lengthen by 
an external force while producing tension (9, 117-119). 
DHR in rodents results in decreased isometric force 
production and elevations in muscle injury makers 
such as creatine kinase activity and muscle injury cri-
teria identified with Hematoxylin and Eosin staining 
(118, 120, 121). DHR is also known to stimulate mus-
cle remodeling and myogenesis processes (121-128). 
DHR induce ~80% up regulation of mitogen-activated 
protein kinase (MAPK) signaling such as phosphory-
lation of JNK, p38, and ERK (129). Myogenic markers 
Myf5, MyoD, Myosin Heavy Chain (MHC), MCadhe-
rin, Desmin, and Pax 7 increase expression within the 
first week following DHR (121-127). There is in-
creased Myf5 transcriptional activity in Myf5LacZ 
reporter mice at 48 hours to 96 hours post DHR (128). 
Overall, there is sufficient data to exhibit that DHR 
induces a myogenic response and may be worthy as a 
model for studying postnatal myogenesis regulation. 
One aspect to consider when using the DHR 
model to study myogenesis is that the time course of 
muscle repair with the DHR model may be different 
than with artificial muscle injury models. There is a 
delay in the onset of muscle regeneration in the DHR 
model relative to cardiotoxin injections (CTX) (122). 
Armand et al. (122) reports that CTX-injured soleus 
fibers exhibit extensive myofiber damage at 24 hours 
to 72 hours post injury, while DHR-injured fibers are 
not apparent until 96 hours to 144 hours post exercise. 
At 120 hours post-CTX, muscle regeneration domi-
nates while signs of muscle repair are not present un-
til 144 hours to 168 hours post-DHR. Although DHR 
does not induce as profound of muscle injury as seen 
in the CTX model, this exercise injury model still in-
duces a myogenic response.  
Besides the DHR model, other eccentric contrac-
tion models are available to study muscle regenera-
tion (130-139). Eccentric contractions on an isokinetic 
dynamometer results in muscle remodeling in the 
hours to days post exercise including increased ex-
pression of hepatocyte growth factor (HGF), MyoD, 
mechano growth factor, neural cell adhesion mole-
cule, Pax7 and insulin-like growth factor 1 (IGF1) 
(134-138). In situ muscle lengthening contraction in-
jury model is a physiological test that uses a rigorous 
and precise control of muscle contraction by electri-
cally stimulating motor neurons of associated muscles 
of interest (130-132, 139). With its ability to quantify 
muscle function this biological model offers a unique 
approach relative to other muscle injury protocol. 
There is a 70%-80% decrease in isometric force pro-
duction and a 15- 20% increase in injured fibers in 
mice EDL at three days following exposure to electri-
cally stimulated lengthening contractions (131). In-
flammation is also present at three days post injury 
with reports of a 7.9 fold and 51.2 fold increase in 
muscle associated neutrophils and macrophages re-
spectively (140). With the profound magnitude of 
muscle injury present in this physiological stimulus 
model as well as the presence of myogenic-associated 
proteins, it seems plausible that one could use this 
novel muscle injury model to study the regulation of 
myogenic repair as it relates to recovery of function.  
Muscle overload techniques (heavy resistance 
exercise, stretch hypertrophy and compensatory 
hypertrophy) are physiological stimuli capable of 
investigating the contribution of myogenic properties 
to growth. Overload-induced muscle hypertrophy is a 
type of a compensatory hypertrophy model in which 
muscles are ablated (such as the gastrocnemius, so-
leus or tibialis anterior) and the remaining muscles 
(such as the plantaris or extensor digitorum longus) 
work harder to maintain muscle function (141). This 
compensation of the remaining muscles results in 
growth including increased DNA synthesis, muscle 
mass and force production (141-148). Overloaded rat 
soleus has a 40% increase in wet weight and ~ 6.76% 
to 12.74% increase in de novo myofibers (142). The 
cross sectional area of a single myofiber as well as 
myonuclei number per millimeter of a myofiber in-
crease at 46% and 44% respectively in an overloaded 
rat plantaris (149). It is suggested that activation of 
satellite cells is a source of the new myonuclei rather 
than sole provision from differentiated myotubes 
(149, 150). Petrella et al. (151) reports that a 117% in-Int. J. Biol. Sci. 2010, 6 
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crease in satellite cells accompanies the 26% increase 
in myonuclei following heavy resistance exercises 
(151). During the early hours and within the first week 
of compensatory overload there is evidence of satellite 
cell activation and myogenic response including 
up-regulated Pax 7, M-Cadherin, MyoD, Desmin, 
Myogenin, MHC as well as fibroblast growth factors 1 
and 7, IGF1 and HGF (142, 145, 147, 148, 152-155).  
The contribution of satellite cells to muscle repair 
and growth is not conclusive. There is evidence sup-
porting the notion that satellite cells are critical to 
muscle repair, recovery of muscle function as well as 
important to muscle growth (142, 149, 156-158). Ir-
radiation-induced inhibition of proliferating myo-
genic cells results in decreased force recovery fol-
lowing injurious eccentric contractions to rodent an-
terior crural muscles (156, 157). Non-irradiated mice 
have complete force recovery at three weeks post ex-
posure to an injurious lengthening protocol while 
irradiated mice exhibit a 35% force deficit (156). In 
addition, MyoD and Myogenin transcripts are in-
creased at three, seven, 14, and 21 days post leng-
thening contractions in non-irradiated mice while 
irradiated mice do not show any MRF up-regulation 
(156). There is evidence of the importance of satellite 
cells in the overload muscle growth models (142, 149). 
Phelan et al. (1997) reports no hypertrophy following 
four weeks of overloading in irradiated rat soleus 
(142). In addition, there is no increase in muscle mass, 
myofibrillar protein, DNA content, or cross sectional 
area of a single myofiber at three months following 
overloading in irradiated rat hindlimb muscle (149). 
However, it needs to be mentioned that there is 
data demonstrating the occurrence of muscle hyper-
trophy without up regulation of myogenic proteins 
following muscle overload and proponents that pro-
pose the critical component for muscle hypertrophy is 
protein synthesis and not satellite cells (159, 160). 
Since IGF1 induces muscle hypertrophy by stimulat-
ing protein production via signaling pathways such as 
PI3K/Akt/mTOR/S6K1 (161-164) investigators from 
this camp manipulate IGF to study the impact of 
protein synthesis on muscle hypertrophy. There is 
increased muscle hypertrophy in overloaded mice 
that over-express muscle IGF1 or Akt (165-167). In 
addition, irradiated mice that are introduced with 
viral-mediated IGF1 gene transfer have greater mus-
cle growth than with just irradiation alone (162).  
To add complication to the controversy, it is also 
proposed that both satellite cells and protein synthesis 
contribute to muscle repair and hypertrophy (162, 
168, 169). Barton Davis et al. (162) identified IGF1 re-
ceptors on satellite cells and differentiated muscle 
fibers (162). They suggest that IGF1 could co-activate 
satellite cells and adult muscle fibers to induce 
hypertrophy so that in conditions in which irradiation 
depletes proliferating activated satellite cells the ma-
ture muscle fibers could be responsible for the in-
creased protein synthesis (162). Others suggest that 
the predominating mechanism of either satellite cell 
activation or increased protein synthesis may be due 
to the timeline of events following a hypertrophic 
stimulus (168, 169). Perhaps “early” hypertrophy is 
due to increased transcription and translation while 
hypertrophy that occurs at later time points may be 
due to increased satellite cell activation, resulting in 
increased myonuclei number (168, 169). More work is 
needed to delineate the importance of protein syn-
thesis compared to satellite cells to muscle repair and 
growth. 
The interaction of physiological stimuli, 
Notch and Wnt, and muscle regeneration 
There are still many questions in regards to the 
contribution of satellite cells to muscle repair and 
growth. Using “global” forms of muscle injury and 
growth such as contraction-induced muscle injury 
models and overload-induced hypertrophy models 
will help identify whether the basis satellite cell acti-
vation is intrinsic, muscle-derived, or arise from other 
systems (nervous, circulatory, inflammatory, etc…). 
Furthermore, studying the communication of cell 
signaling pathways important for muscle regenera-
tion (such as Notch, Wnt) as relates to satellite cell 
activation will aid in delineating the source of satellite 
cell activation resulting in determining the impor-
tance satellite cells to muscle repair and growth. Re-
search on the interaction of physiological stimuli, 
Notch and Wnt signaling and muscle repair and 
growth would aid in furthering the understanding of 
satellite cell regulation. Physiological stimuli 
up-regulates components of Notch and Wnt signaling 
(92, 127, 170-175). DHR increases Notch1 and Delta1 
expression in myogenic cells at 72 hours through 120 
hours post-injury (127). A single injurious bout of 
resistance exercise increases Notch1 and downstream 
regulator Hes6 mRNA (170). Overload-induced 
hypertrophy also increases Notch1 expression in 
Pax7-positive myogenic cells (171). In vivo exercise 
decreases GSK3ß activity and ß-catenin phosphoryla-
tion which is required for Wnt signaling activation 
(173, 174). Overload-induced hypertrophy 
up-regulates total ß-catenin, receptor Frizzled1, Wnt 
regulator Disheveled1, Wnt downstream target genes 
cmyc and Cyclin D1 as well as induce a 434% increase 
in nuclear ß-catenin and promotion of ß-catenin/LEF1 
complex formation (172, 175). There is evidence that 
ß-catenin may be required for muscle hypertrophy Int. J. Biol. Sci. 2010, 6 
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since there is no hypertrophy in overloaded mice with 
conditional inactivation of ß-catenin (92). There is an 
abundance of evidence stating that physiological 
stimuli up-regulates Notch and Wnt signaling but 
more research is needed on the effect of physiological 
stimuli on the orchestration and regulation of these 
signaling pathways during muscle repair. 
Conclusion 
With the development of tools available to iden-
tify satellite cells, it is feasible to study the characte-
rization and regulation of postnatal myogenesis. More 
work is needed to discern the factor(s) responsible for 
re-awakening these normally quiescent skeletal mus-
cle stem cells as well as to determine the collaboration 
of the various signaling mechanisms as relates to re-
gulating the myogenic proteins. Notch and Wnt sig-
naling have recently been identified to be critical to 
muscle regeneration. The revelation of the importance 
of Notch and Wnt signaling to during muscle repair is 
recognized in artificial muscle injury models but is 
largely unknown in physiological stimuli models. 
Contracting skeletal muscle releases a plethora of 
signals that induces autocrine and paracrine effects 
that may influence the regulation of postnatal myo-
genesis differently than localized muscle injury mod-
els. Therefore, understanding the intrinsic and sys-
temic response of contracting muscle will aid in de-
ciphering the regulation of satellite cells and muscle 
repair as well as understanding the molecular me-
chanisms responsible for the beneficial protective ef-
fects of exercise to cardiovascular disease and cancer.  
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